1225 CHARACTERIZATION OF VIRAL RESISTANCE MUTATIONS IN GENOTYPE 1 HCV PATIENTS RECEIVING COMBINATION THERAPY WITH A PROTEASE INHIBITOR AND A POLYMERASE INHIBITOR WITH OR WITHOUT RIBAVIRIN
Mo, H., Harris, J., Bae, A., Hebner, C., Wong, K., Delaney, W., Oldach, D., Miller, M.D.Volume:
54
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(11)61227-0
Date:
March, 2011
File:
PDF, 42 KB
english, 2011